May 3, 2018 / 12:44 PM / 7 months ago

BRIEF-Hemostemix Announces Departure Of David Berman As CFO

May 3 (Reuters) - Hemostemix Inc:

* HEMOSTEMIX ANNOUNCES FIRST PATIENT TREATED IN PHASE II CLINICAL TRIAL

* HEMOSTEMIX INC - ANNOUNCES DEPARTURE OF DAVID BERMAN FROM POSITION OF CHIEF FINANCIAL OFFICER

* HEMOSTEMIX INC - KRISTIN GULKA JOINS HEMOSTEMIX IN CAPACITY OF CFO Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below